OVERVIEW
The global market size of flow cytometry is expected to hit USD 6.43 billion by 2025, increasing over the forecast period at a CAGR of 8.33 per cent. Market growth is driven largely by factors such as technological advancements in flow cytometers, increased adoption of flow cytometry techniques in science and clinical trials, increased emphasis on immunology and immuno-oncology studies, increased integration of AI technologies in flow cytometry workflows and advancements in flow cytometry software, high incidence and prevalence of flow cytometry.
TABLE OF CONTENT
1 Global Flow Cytometry Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Flow Cytometry Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Flow Cytometry Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Flow Cytometry Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Flow Cytometry Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Flow Cytometry Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Flow Cytometry Market – By Product and Service (Market Size – & million/billion)
8.1 Reagents and Consumables
8.2 Instruments
8.3 Services
8.4 Software
8.5 Accessories
9 Global Flow Cytometry Market – By Technology
9.1 Cell-based Flow Cytometry
9.2 Bead-based Flow Cytometry
10 Global Flow Cytometry Market – By Application
10.1 Research Applications
10.2 Clinical Applications
10.3 Industrial Applications
11 Global Flow Cytometry Market – By End-User
11.1 Academic & Research Institutes
11.2 Hospitals & Clinical Testing Laboratories
11.3 Pharmaceutical & Biotechnology Companies
12 Global Flow Cytometry Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global Flow Cytometry Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global Flow Cytometry Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Becton, Dickinson and Company
14.3 Beckman Coulter (A Subsidiary of Danaher)
14.4 Thermo Fisher Scientific
14.5 Miltenyi Biotec
14.6 Enzo Life Sciences, Inc. (A Subsidiary of Enzo Biochem)
14.7 Merck KGaA
14.8 Sony Biotechnology (A Subsidiary of Sony Corporation of America)
14.9 Luminex Corporation
14.10 Agilent Technologies
14.11 Bio-Rad Laboratories
14.12 Company 11 & more
15 Global Flow Cytometry Market – Appendix
15.1 Sources
15.2 Abbreviations
